# [Retracted] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway

**Authors:** Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu, Yang Zhang, Ailin Song

PMC · DOI: 10.3892/mmr.2025.13508 · 2025-03-31

## Full-text entities

- **Genes:** MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** breast cancer (MESH:D001943)
- **Chemicals:** Everolimus (MESH:D000068338)

---
Source: https://tomesphere.com/paper/PMC11979568